In the glucocorticoid-induced osteoporosis (GIOP) rat model, administration of liraglutide at a dose of ~ 53 nmol/kg/day did not result in significant weight loss [59]
This product has not been evaluated by the FDA or any regulatory authority for medical use
There are also a similar class of drugs, called tirzepatide, and those include meds Mounjaro (for type 2 diabetes) and Zepbound (for weight loss)
Peralta and Lizcano, 2024)
Applying those same ingredients to the skin introduces an absorption barrier that has not been validated for this purpose (7,9,10), and no Australia regulator has approved any over-the-counter GLP-1 patch for safety or efficacy
If you dont have a doctor, then we have resources on this website to help you